# Prologis, Inc.: overview

PLD · NYSE · CIK 1045609 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pld.md) · [Financials](/companies/pld/financials.md) · [Filings](/companies/pld/filings.md) · [Insiders](/companies/pld/insiders.md)

Latest reported revenue: [$2.30bn](/filings/0001193125-26-197850.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed Apr 30, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-197850).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,008](/filings/0001193125-26-051453.md) | [2,036](/filings/0001193125-26-051453.md) | [2,201](/filings/0001193125-26-051453.md) | [2,140](/filings/0001193125-26-197850.md) | [2,184](/filings/0001193125-26-051453.md) | [2,214](/filings/0001193125-26-051453.md) | [2,253](/filings/0001193125-26-051453.md) | [2,298](/filings/0001193125-26-197850.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [51.0%](/filings/0001193125-26-051453.md) | [61.4%](/filings/0001193125-26-051453.md) | [64.6%](/filings/0001193125-26-051453.md) | [41.1%](/filings/0001193125-26-197850.md) | [41.8%](/filings/0001193125-26-051453.md) | [42.5%](/filings/0001193125-26-051453.md) | [72.2%](/filings/0001193125-26-051453.md) | [52.7%](/filings/0001193125-26-197850.md) |
| Net margin | % | [42.9%](/filings/0000950170-25-099770.md) | [49.4%](/filings/0001193125-25-253512.md) | [61.0%](/filings/0001193125-26-051453.md) | [27.7%](/filings/0001193125-26-197850.md) | [26.2%](/filings/0000950170-25-099770.md) | [34.5%](/filings/0001193125-25-253512.md) | [65.8%](/filings/0001193125-26-051453.md) | [42.7%](/filings/0001193125-26-197850.md) |
| Diluted EPS | $ per share | [0.92](/filings/0001193125-26-051453.md) | [1.08](/filings/0001193125-26-051453.md) | [1.37](/filings/0001193125-26-051453.md) | [0.63](/filings/0001193125-26-197850.md) | [0.61](/filings/0001193125-26-051453.md) | [0.82](/filings/0001193125-26-051453.md) | [1.49](/filings/0001193125-26-051453.md) | [1.05](/filings/0001193125-26-197850.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,759](/filings/0000950170-24-014539.md) | [5,974](/filings/0000950170-25-021272.md) | [8,023](/filings/0001193125-26-051453.md) | [8,202](/filings/0001193125-26-051453.md) | [8,790](/filings/0001193125-26-051453.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [67.4%](/filings/0000950170-24-014539.md) | [58.0%](/filings/0000950170-25-021272.md) | [46.2%](/filings/0001193125-26-051453.md) | [53.8%](/filings/0001193125-26-051453.md) | [49.6%](/filings/0001193125-26-051453.md) |
| Net margin | % | [61.8%](/filings/0000950170-24-014539.md) | [56.3%](/filings/0000950170-25-021272.md) | [38.1%](/filings/0001193125-26-051453.md) | [45.5%](/filings/0001193125-26-051453.md) | [37.9%](/filings/0001193125-26-051453.md) |
| Diluted EPS | $ per share | [3.94](/filings/0000950170-24-014539.md) | [4.25](/filings/0000950170-25-021272.md) | [3.29](/filings/0001193125-26-051453.md) | [4.01](/filings/0001193125-26-051453.md) | [3.56](/filings/0001193125-26-051453.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pld/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $14.01bn | 103,392,538 |  | Added +2,978,479 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.25bn | 60,904,443 |  | Added +596,026 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.57bn | 55,915,113 |  | Reduced −118,153 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $7.49bn | 55,255,790 |  | Added +1,377,035 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.22bn | 23,889,351 |  | Added +278,318 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $2.68bn | 19,264,378 |  | Reduced −1,337,605 |
| [APG Asset Management US Inc.](/funds/1323255.md) | 2026-06-30 | $2.64bn | 19,286,830 |  | Unchanged |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $2.34bn | 17,258,306 |  | Added +703,871 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $2.16bn | 15,915,752 |  | Reduced −1,024,666 |
| [UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC](/funds/861177.md) | 2026-06-30 | $2.00bn | 14,753,884 |  | Added +618,467 |

## Recent filings

[All 2,301 filings](/companies/pld/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:02 ET | [8-K](/filings/0001104659-26-120653.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-120653 |
| 2026-10-28 | 16:14 ET | [10-Q](/filings/0001193125-26-436160.md) | Quarterly report, period 2026-09-30 | 0001193125-26-436160 |
| 2026-10-15 | 09:18 ET | [8-K](/filings/0001193125-26-422375.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422375 |
| 2026-08-06 | 16:36 ET | [8-K](/filings/0001104659-26-092072.md) | 8.01 Other events | 0001104659-26-092072 |
| 2026-08-05 | 07:22 ET | [8-K](/filings/0001104659-26-090724.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-090724 |
| 2026-08-04 | 06:01 ET | [8-K](/filings/0001104659-26-089980.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089980 |
| 2026-07-29 | 16:13 ET | [10-Q](/filings/0001193125-26-323746.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323746 |
| 2026-07-16 | 08:05 ET | [8-K](/filings/0001193125-26-305416.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-305416 |
| 2026-07-01 | 08:37 ET | [8-K](/filings/0001193125-26-291634.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-291634 |
| 2026-06-24 | 06:19 ET | [8-K](/filings/0001193125-26-280195.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-280195 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-051453.md), filed Feb 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1045609
- Tickers: PLD, PLDGP
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:04 ET. No prices; not investment advice.